PRESS RELEASE: Dr. Claus Vielsack appointed member of the management board of STRATEC for Product Development

PRESS RELEASE: Dr. Claus Vielsack appointed member of the management board of STRATEC for Product Development

DGAP-News: STRATEC Biomedical AG / Key word(s): Change of Personnel Dr. Claus Vielsack appointed member of the management board of STRATEC for Product Development

17.02.2014 / 10:04

=--------------------------------------------------------------------

Dr. Claus Vielsack appointed member of the management board of STRATEC for Product Development

Birkenfeld, February 17, 2014

STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) announces the appointment of Dr. Claus Vielsack (46) to the Board of Management of STRATEC as Product Development Director, effective February 15, 2014. Dr. Vielsack expands the current Board of Management, comprising Marcus Wolfinger, Dr. Robert Siegle and Bernd M. Steidle, and will be responsible for the group-wide management of product development, an area for which he has borne responsibility since 2011 in his capacity as Senior Vice President.

Dr. Vielsack has held various senior product development positions at STRATEC since 1998. Before joining STRATEC, he held a number of different positions working as a program manager in the development of chemical applications and software solutions. Dr. Vielsack holds a degree in chemistry from the University of Konstanz, where he also obtained his doctorate in physical chemistry.

Marcus Wolfinger, Chairman of the Board of Management of STRATEC Biomedical AG: 'The appointment of Dr. Claus Vielsack as Development Director underlines the importance this company division has for the further growth of the STRATEC Group. Claus Vielsack has worked at STRATEC in various senior positions within product development for more than 15 years now. He is a respected colleague and enjoys the utmost trust among our customers and partners. His all-round understanding of the latest technologies and developments in our industry is already reflected in numerous product solutions in place at our partners. We are therefore delighted to welcome Dr. Vielsack to the Board of Management.'

Comments Dr. Claus Vielsack: 'I look forward to working together with a highly motivated, internationally proven team to help shape our company's future. STRATEC is consistently expanding its development activities at various locations to enable us to offer our partners ideal solutions along the entire value chain. STRATEC's growing market share and the great trust placed in the company by leading diagnostics players are also reflected in the major development projects recently acquired. These in turn will underpin STRATEC's future growth.'

Read the original here:
PRESS RELEASE: Dr. Claus Vielsack appointed member of the management board of STRATEC for Product Development

Related Posts

Comments are closed.